Clinical Behavior, Management, and Treatment Response of Estrogen Receptor Low (1-10%) Breast Cancer.

Moldoveanu, Dan; Hoskin, Tanya L; Day, Courtney N; Schulze, Amy K; Goetz, Matthew P; Boughey, Judy C

Moldoveanu, Dan; Hoskin, Tanya L; Day, Courtney N; Schulze, Amy K; Goetz, Matthew P; Boughey, Judy C.

Affiliation

Moldoveanu D; Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA.
Hoskin TL; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Day CN; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Schulze AK; Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA.
Goetz MP; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Boughey JC; Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA. boughey.judy@mayo.edu.

Ann Surg Oncol ; 30(11): 6475-6483, 2023 Oct.

Article in En | MEDLINE | ID: mdl-37460743

Subject(s)

Breast Neoplasms; Humans; Female; Breast Neoplasms/pathology; Receptors, Estrogen/metabolism; Ki-67 Antigen; Receptor, ErbB-2/metabolism; Neoadjuvant Therapy; Receptors, Progesterone/metabolism; Biomarkers, Tumor

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Year: 2023 Type: Article